Clinical trial
Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab
NCT03457818 is registered in ClinicalTrials.gov with Mishaela Rubin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab
- Lead sponsor
- Mishaela Rubin
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 7, 2018
- Completion date
- June 10, 2020
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.